2BB score and signals
Prelude Therapeutics Incorporated’s current 2BB score is 46 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 69 | High |
| Momentum | 96 | Strongly Improving |
| Financial strength | 21 | Weak |
| Quality | 80 | Very Strong |
| Risk | 49 | Moderate |
Company facts
| Headquarters | Wilmington, Delaware, United States |
| Founded | 2016 |
| Employees | 79 |
| 52-week range | $0.81 – $5.90 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | 0.2244 | — | $54.05M |
| 2026-08-19 | — | -0.2006 | — | $0.00 |
| 2026-05-12 | -0.13 | -0.2533 | $4.58M | $0.00 |
| 2026-03-10 | -0.2 | -0.0296 | $5.64M | $35.70M |
Related companies
2BBBullish & Bearish